Latest News and Press Releases
Want to stay updated on the latest news?
-
NORTHBROOK, Ill., April 7, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that a 20-to-1 reverse split of...
-
NORTHBROOK, Ill., March 25, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, and Scripps Health, a private, nonprofit,...
-
NORTHBROOK, Ill., March 12, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, offers the Verigene® Gram-Negative Blood...
-
NORTHBROOK, Ill., March 3, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will conduct a special...
-
Corporate Highlights and Guidance: Record fourth quarter and fiscal year revenues of $4.6 million, and $14.3 million, respectively 47 new customer placements in the fourth...
-
NORTHBROOK, Ill., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...
-
Corporate Highlights: Record fourth quarter and fiscal year preliminary revenue of $4.6 million and $14.3 million, respectively 47 new customer placements in fourth quarter Roger Moody...
-
NORTHBROOK, Ill., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report preliminary...
-
Corporate Highlights and Business Guidance: Q3 2014 revenues of $3.7 million, a 56% increase over Q3 2013, and 30 new customer placements. Received FDA clearance of Verigene®...
-
NORTHBROOK, Ill., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...